Consolidated Statements of Cash Flows - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2023	Jan. 01, 2023	Jan. 02, 2022
Cash flows from operating activities
Net earnings	$ 35,153	$ 17,941	$ 20,878
Adjustments to reconcile net earnings to cash flows from operating activities:
Depreciation and amortization of property and intangibles	7,486	6,970	7,390
Stock based compensation	1,162	1,138	1,135
Asset write-downs	1,295	1,216	989
Charge for purchase of in-process research and development assets	483	0	0
(Gain) on separation of Kenvue	(20,984)	0	0
Net gain on sale of assets/businesses	(117)	(380)	(617)
Deferred tax provision	(4,194)	(1,663)	(2,079)
Credit losses and accounts receivable allowances	0	(17)	(48)
Changes in assets and liabilities, net of effects from acquisitions and divestitures:
Increase in accounts receivable	(624)	(1,290)	(2,402)
Increase in inventories	(1,323)	(2,527)	(1,248)
Increase in accounts payable and accrued liabilities	2,346	1,098	2,437
(Increase)/Decrease in other current and non-current assets	(3,480)	687	(1,964)
Increase/(Decrease) in other current and non-current liabilities	5,588	(1,979)	(1,061)
Net cash flows from operating activities	22,791	21,194	23,410
Cash flows from investing activities
Additions to property, plant and equipment	(4,543)	(4,009)	(3,652)
Proceeds from the disposal of assets/businesses, net	358	543	711
Acquisitions, net of cash acquired	0	(17,652)	(60)
Purchases of in-process research and development assets	(470)	0	0
Purchases of investments	(10,906)	(32,384)	(30,394)
Sales of investments	19,390	41,609	25,006
Credit support agreements activity, net	(2,963)	(249)	214
Other (including capitalized licenses and milestones)	12	(229)	(508)
Net cash from/(used) by investing activities	878	(12,371)	(8,683)
Cash flows from financing activities
Dividends to shareholders	(11,770)	(11,682)	(11,032)
Repurchase of common stock	(5,054)	(6,035)	(3,456)
Proceeds from short-term debt	13,743	16,134	1,997
Repayment of short-term debt	(22,973)	(6,550)	(1,190)
Proceeds from long-term debt, net of issuance costs	0	2	5
Repayment of long-term debt	(1,551)	(2,134)	(1,802)
Proceeds from the exercise of stock options/employee withholding tax on stock awards, net	1,094	1,329	1,036
Credit support agreements activity, net	(219)	(28)	281
Proceeds of short and long-term debt, net of issuance cost, related to the debt that transferred to Kenvue at separation	8,047	0	0
Proceeds from Kenvue initial public offering	4,241	0	0
Cash transferred to Kenvue at separation	(1,114)	0	0
Other	(269)	93	114
Net cash used by financing activities	(15,825)	(8,871)	(14,047)
Effect of exchange rate changes on cash and cash equivalents	(112)	(312)	(178)
Increase/(Decrease) in cash and cash equivalents	7,732	(360)	502
Cash and cash equivalents from continuing operations, beginning of period	12,889	13,309	12,697
Cash and cash equivalents from discontinued operations, beginning of period	1,238	1,178	1,288
Cash and cash equivalents, beginning of year	14,127	14,487	13,985
Cash and cash equivalents from continuing operations, end of period	21,859	12,889	13,309
Cash and cash equivalents from discontinued operations, end of period	0	1,238	1,178
Cash and cash equivalents, end of year	21,859	14,127	14,487
Cash paid during the year for:
Interest	1,836	982	990
Interest, net of amount capitalized	1,766	933	941
Income taxes, inclusive of discontinued operations	8,574	5,223	4,768
Supplemental schedule of non-cash investing and financing activities
Treasury stock issued for employee compensation and stock option plans, net of cash proceeds/ employee withholding tax on stock awards	1,435	2,114	1,811
Acquisitions
Fair value of assets acquired	0	18,710	61
Fair value of liabilities assumed	0	(1,058)	(1)
Noncash or Part Noncash Acquisition, Net Nonmonetary Assets Acquired (Liabilities Assumed), Total	$ 0	$ 17,652	$ 60